Follow the TS트릴리온 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, TS트릴리온 has recorded 108 reports. Market capitalisation: €34.8bn. The latest transaction was filed on 27 May 2026 (Purchase). Among the most active insiders: 디에스조합. The full history is accessible without an account.
106
Insider Decl.
n/a
Thresholds
n/a
76 ops.
Buy Volume
€7m
7 ops.
Sell Volume
2Σ signal
Buys n/a€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,588 of 29,056 companies
32.4
score / 100
Value
36
Quality
29
FCF yld13%
Earn yld-5.8%
EV/EBITDA46.6x
ROE-2.2%
Gross mgn55%
Net mgn-7.7%
Debt/EBITDA17.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
TS트릴리온 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.